Beth Chasen

4.0k total citations · 1 hit paper
35 papers, 576 citations indexed

About

Beth Chasen is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Beth Chasen has authored 35 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Epidemiology and 11 papers in Neurology. Recurrent topics in Beth Chasen's work include Neuroendocrine Tumor Research Advances (13 papers), Lung Cancer Research Studies (12 papers) and Neuroblastoma Research and Treatments (9 papers). Beth Chasen is often cited by papers focused on Neuroendocrine Tumor Research Advances (13 papers), Lung Cancer Research Studies (12 papers) and Neuroblastoma Research and Treatments (9 papers). Beth Chasen collaborates with scholars based in United States, United Kingdom and Netherlands. Beth Chasen's co-authors include Colleen M. Costelloe, Adi Diab, Rodabe N. Amaria, Priyadharsini Nagarajan, Víctor G. Prieto, Michael T. Tetzlaff, Gregg Staerkel, Jonathan L. Curry, Carlos A. Torres‐Cabala and Kelly C. Nelson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Beth Chasen

31 papers receiving 568 citations

Hit Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus hi... 2024 2026 2025 2024 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
    2024 113 citations Simron Singh, Daniel Halperin et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beth Chasen United States 13 297 219 164 155 142 35 576
Ulrike Garske Sweden 13 442 1.5× 432 2.0× 296 1.8× 137 0.9× 285 2.0× 21 902
Angelina Filice Italy 15 289 1.0× 323 1.5× 230 1.4× 167 1.1× 186 1.3× 53 772
Timothy F. Kozelsky United States 11 352 1.2× 178 0.8× 67 0.4× 388 2.5× 86 0.6× 17 718
Michael Mac Manus Australia 12 283 1.0× 154 0.7× 341 2.1× 375 2.4× 53 0.4× 20 777
Cristian Rapicetta Italy 15 282 0.9× 109 0.5× 51 0.3× 418 2.7× 59 0.4× 60 742
Çiğdem Soydal Türkiye 16 240 0.8× 145 0.7× 305 1.9× 293 1.9× 53 0.4× 98 730
İşık Adalet Türkiye 15 221 0.7× 225 1.0× 145 0.9× 165 1.1× 136 1.0× 40 714
Raj Singh United States 11 177 0.6× 78 0.4× 66 0.4× 266 1.7× 50 0.4× 50 485
Manu Shastry United Kingdom 12 111 0.4× 67 0.3× 367 2.2× 184 1.2× 44 0.3× 16 541

Countries citing papers authored by Beth Chasen

Since Specialization
Citations

This map shows the geographic impact of Beth Chasen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Chasen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Chasen more than expected).

Fields of papers citing papers by Beth Chasen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Chasen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Chasen. The network helps show where Beth Chasen may publish in the future.

Co-authorship network of co-authors of Beth Chasen

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Chasen. A scholar is included among the top collaborators of Beth Chasen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Chasen. Beth Chasen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravizzini, Gregory, et al.. (2025). Comparison of Three Therapeutic Radiopharmaceutical Infusion Methods for Single and Multivial Applications. Journal of Nuclear Medicine Technology. 53(3). 187–192.
2.
3.
Dasari, Arvind, et al.. (2024). Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy. Endocrine Related Cancer. 31(4). 8 indexed citations
4.
Singh, Simron, Daniel Halperin, Sten Myrehaug, et al.. (2024). [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. The Lancet. 403(10446). 2807–2817. 113 indexed citations breakdown →
5.
6.
7.
Johnson, Jason M., Melissa Chen, Eric Rohren, et al.. (2021). Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing. Frontiers in Neurology. 12. 740280–740280. 5 indexed citations
8.
Strosberg, Jonathan, Rajaventhan Srirajaskanthan, Ghassan El‐Haddad, et al.. (2021). Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE. Journal of Nuclear Medicine. 62(12). 1712–1718. 14 indexed citations
9.
Mahvash, Armeen, James P. Long, Mohamed E. Abdelsalam, et al.. (2020). <p>Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients</p>. Journal of Hepatocellular Carcinoma. Volume 7. 117–131. 17 indexed citations
10.
Jensen, Corey T., et al.. (2020). Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer. Clinical Nuclear Medicine. 46(4). 355–357. 3 indexed citations
11.
Ueno, Naoto T., Takeo Fujii, James M. Reuben, et al.. (2019). Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer. Cancer Medicine. 9(3). 1025–1032. 22 indexed citations
12.
Tetzlaff, Michael T., Kelly C. Nelson, Adi Diab, et al.. (2018). Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. Journal for ImmunoTherapy of Cancer. 6(1). 14–14. 116 indexed citations
13.
Lü, Yang, Beth Chasen, & Homer A. Macapinlac. (2017). Imaging Characteristics of Chemotherapy Related Adult-Onset Still Disease. Clinical Nuclear Medicine. 42(12). 980–982.
14.
Somcio, Ray, et al.. (2016). Increased 18F-FDG Uptake Associated With Gastric Banding Surgical Mesh on PET/CT. Clinical Nuclear Medicine. 41(5). 410–411. 2 indexed citations
15.
Aloia, Thomas A., et al.. (2015). 18F-FDG Uptake at the Surgical Margin after Hepatic Resection: Patterns of Uptake and Differential Diagnosis. European Radiology. 25(8). 2453–2459. 1 indexed citations
16.
17.
Mahvash, Armeen, et al.. (2012). Temporary Balloon Occlusion of the Common Hepatic Artery for Administration of Yttrium-90 Resin Microspheres in a Patient with Patent Hepatoenteric Collaterals. Journal of Vascular and Interventional Radiology. 23(2). 277–280. 16 indexed citations
18.
Mahvash, Armeen, et al.. (2012). Abstract No. 161: Balloon-catheter occlusion technique for adminstration of Y90 microspheres in patients with patent hepatoenteric arteries. Journal of Vascular and Interventional Radiology. 23(3). S67–S68. 1 indexed citations
19.
Costelloe, Colleen M., Vikas Kundra, Jingfei Ma, et al.. (2011). Fast dixon whole‐body MRI for detecting distant cancer metastasis: a preliminary clinical study. Journal of Magnetic Resonance Imaging. 35(2). 399–408. 31 indexed citations
20.
Gayed, Isis, Joe H. Chang, Rodolfo Núñez, et al.. (2008). Lung Perfusion Imaging Can Risk Stratify Lung Cancer Patients for the Development of Pulmonary Complications after Chemoradiation. Journal of Thoracic Oncology. 3(8). 858–864. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrike Garske Breakdown of academic impact, for papers by Angelina Filice Breakdown of academic impact, for papers by Timothy F. Kozelsky Breakdown of academic impact, for papers by Michael Mac Manus Breakdown of academic impact, for papers by Cristian Rapicetta Breakdown of academic impact, for papers by Çiğdem Soydal Breakdown of academic impact, for papers by İşık Adalet Breakdown of academic impact, for papers by Raj Singh Breakdown of academic impact, for papers by Manu Shastry
Rankless by CCL
2026